Help us: Donate
Follow us on:

October 2019 MMTP Update


It has been a while since the last update from MMTP, so we wanted to let you know how things are progressing. 

As we explained in the last update, the internal review board (IRB) has concerns and further questions relating to the ethics of life extension and lifespan studies, and we are continuing to try to resolve these issues in order to be permitted to launch the study. The team has responded to the IRB, and the proposed lifespan study is under review once again.

Unfortunately, until the IRB responds, we cannot say if or when the lifespan study will be approved. This is disappointing news, and it also touches upon a wider issue in Europe, where, currently, high-quality lifespan studies are just not done in relation to life extension, and there is resistance to the idea.

This means it is more important than ever to continue fighting to get this study launched because if we do not keep pushing, no studies will ever be approved in the future, and Europe will not be part of lifespan studies supporting life extension. Therefore, this has become an important fight to change the system, and Dr. Stolzing is working hard to win this fight to open up lifespan studies in Europe that support the development of therapies that target aging.

That is the bad news, but there is also some good news too. While the team has been waiting, it has conducted some useful in vitro testing with a variety of senolytic compounds in various combinations. The team has already prepared the figures and methods and is currently preparing the experimental manuscript prior to submitting its findings for journal publication. The publication process can be time consuming, like many things in science, but the in vitro findings should prove interesting once published. 

We will keep you posted on developments as things change, and, hopefully soon, we will have some more positive news to report.

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.

All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.

Our Organization Grows to Support Rejuvenation Research

Spring is not far away here in the Northern Hemisphere, and with it, the signs of life and new growth...

New Year, Same Goal to End Age-Related Diseases

The new year is well underway, and we have been our usual busy selves. Join us for the first editorial...

Wishing You a Happy Holiday and a Healthy New Year!

While our team is taking some well earned rest and relaxation over Christmas (very important for health and longevity) we...

Raising Awareness that Aging is a Problem Worth Solving

  There has been plenty going on here at, so we thought it was time to give you a...

About the author

Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 600 articles on the topic, interviewed over 100 of the leading researchers in the field, hosted livestream events focused on aging, as well as attending various medical industry conferences. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, Swiss Monthly, Keep me Prime, and New Economy Magazine. Steve is one of three recipients of the 2020 H+ Innovator Award and shares this honour with Mirko Ranieri – Google AR and Dinorah Delfin – Immortalists Magazine. The H+ Innovator Award looks into our community and acknowledges ideas and projects that encourage social change, achieve scientific accomplishments, technological advances, philosophical and intellectual visions, author unique narratives, build fascinating artistic ventures, and develop products that bridge gaps and help us to achieve transhumanist goals. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project.
  1. raphbot
    November 2, 2019

    Hello guys,

    At which point do you realize some regulations are just toxic and either ignore them or move on to more favorable countries?

    I may have missed it but was there a reason to choose and cling to a country so backward and rigid as Germany?

Write a comment:


Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.